22-47 Dr. James Mackey, President & CEO, Aristea Therapeutics

1 Views· 12/04/22
BioTech Nation ... with Dr. Moira Gunn
0

Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's called PPP, or Palmoplantar Pustulosis. Dr. James Mackey is the President & CEO of Aristea Therapeutics.

Show more

 0 Comments sort   Sort By


Up next